España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Surgery Partners
SGRY
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$21.37
0.36
1.71%
At close: -
$21.37
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Surgery Partners (SGRY) Forecast
News
Earnings
Surgery Partners (SGRY) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Surgery Partners (NASDAQ:SGRY) Stock
Surgery Partners Stock (NASDAQ: SGRY)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 03, 2024
JP Morgan Maintains Neutral on Surgery Partne...
Benzinga Newsdesk
Wednesday, November 20, 2024
Key Takeaways From Surgery Partners Analyst Ratings
Benzinga Insights
RBC Capital Maintains Outperform on Surgery P...
Benzinga Newsdesk
Tuesday, November 19, 2024
Macquarie Maintains Outperform on Surgery Par...
Benzinga Newsdesk
Wednesday, November 13, 2024
Macquarie Maintains Outperform on Surgery Par...
Benzinga Newsdesk
Tuesday, November 12, 2024
Surgery Partners shares are trading lower aft...
Benzinga Newsdesk
Surgery Partners Q3 Adj $0.19 Misses $0.25 Es...
Benzinga Newsdesk
Surgery Partners Reaffirmed 2024 outlook: rev...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 04, 2024
Decoding 9 Analyst Evaluations For Surgery Partners
Benzinga Insights
Macquarie Maintains Outperform on Surgery Par...
Benzinga Newsdesk
Friday, October 25, 2024
Shares of healthcare stocks and hospital oper...
Benzinga Newsdesk
Friday, October 11, 2024
Keybanc Initiates Coverage On Surgery Partner...
Benzinga Newsdesk
Friday, October 04, 2024
9 Analysts Assess Surgery Partners: What You Need To Know
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Su...
Benzinga Newsdesk
Friday, September 27, 2024
Here's Why Surgery Partners Could Be the Next Hot Takeover
MarketBeat
Monday, August 26, 2024
Benchmark Reiterates Buy on Surgery Partners,...
Benzinga Newsdesk
Friday, August 23, 2024
TPG, UnitedHealth Are Said Among Suitors For ...
Benzinga Newsdesk
Tuesday, August 20, 2024
Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst
Vandana Singh
Cantor Fitzgerald Reiterates Overweight on Su...
Benzinga Newsdesk
Monday, August 19, 2024
What 8 Analyst Ratings Have To Say About Surgery Partners
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Su...
Benzinga Newsdesk
Wednesday, August 07, 2024
Citigroup Maintains Buy on Surgery Partners, ...
Benzinga Newsdesk
Benchmark Reiterates Buy on Surgery Partners,...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on Surgery ...
Benzinga Newsdesk
Tuesday, August 06, 2024
Surgery Partners shares are trading higher af...
Benzinga Newsdesk
Surgery Partners Q2 Adj $0.21 Beats $0.20 Est...
Benzinga Newsdesk
Sunday, July 21, 2024
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
Lekha Gupta
Friday, July 19, 2024
Surgery Partners shares are trading higher fo...
Benzinga Newsdesk
Bloomberg Reported Late Thursday Surgery Part...
Benzinga Newsdesk
Wednesday, July 10, 2024
Cantor Fitzgerald Reiterates Overweight on Su...
Benzinga Newsdesk
Tuesday, July 09, 2024
Cantor Fitzgerald Reiterates Overweight on Su...
Benzinga Newsdesk
Tuesday, July 02, 2024
Cantor Fitzgerald Reiterates Overweight on Su...
Benzinga Newsdesk
Friday, June 28, 2024
Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know
Benzinga Insights
Macquarie Initiates Coverage On Surgery Partn...
Benzinga Newsdesk
Tuesday, June 04, 2024
Surgery Partners Recent Insider Activity
Benzinga Insights
Wednesday, May 08, 2024
Citigroup Maintains Buy on Surgery Partners, ...
Benzinga Newsdesk
Tuesday, May 07, 2024
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Surgery Partners shares are trading higher fo...
Benzinga Newsdesk
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Surgery Partners Q1 2024 Adj EPS $0.10 Beats ...
Benzinga Newsdesk
Wednesday, May 01, 2024
Benchmark Reiterates Buy on Surgery Partners,...
Benzinga Newsdesk
Wednesday, April 10, 2024
Cantor Fitzgerald Reiterates Overweight on Su...
Benzinga Newsdesk
Wednesday, March 06, 2024
Barclays Initiates Coverage On Surgery Partne...
Benzinga Newsdesk
Tuesday, March 05, 2024
Expert Ratings For Surgery Partners
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Su...
Benzinga Newsdesk
Thursday, February 29, 2024
RBC Capital Reiterates Outperform on Surgery ...
Benzinga Newsdesk
Tuesday, February 27, 2024
Citigroup Maintains Buy on Surgery Partners, ...
Benzinga Newsdesk
Cantor Fitzgerald Maintains Overweight on Sur...
Benzinga Newsdesk
Monday, February 26, 2024
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch